Drugrunner, It is informative. The relentless cycle of 24/7/365 negativity/anger, shorts in shareholders clothing, FUD, years, so much volume posts, a form of fake-goodwill-bashing... All of that means only one thing.
Any substance these Short's arguments and tactics originally had, if any, has all been spent now, all played out.
- Their shorting and spoofing of shares has been absorbed by patient Retail buying.
- NWBO's R&D "risk phase" has been resolved. The landmark global Phase 3 GBM trial was a resounding success and as is supported by the JAMA publication and authored by 70+ oncologists
- Allegations of bad management has been debunked. Instead there's been strategic acquisitions of Flaskworks and Roswell, Sawston state-of-the-art mfg facility, and the vision of Franchise / global immunotherapy platform.
- Most importantly, the DCVax-L MAA train has already left the station and has now obtained sufficient speed and momentum to deliver a giant breakthrough approval.
So the clarity in all this might possibly be:
- the Short's are spent
- incoming new money investors are poised to step in
- the DCVax platform is positioned to transform the future of cancer therapy
- and NWBO is a real emerging unicorn company possibility offering a rare asymmetric risk-reward investment opportunity, both near and long term.
Bullish
Market Data 
Markets 
